Monday, October 6, 2008

Dendreon Shares Climb on Promising Prostate Cancer Data

Early results from a study of a vaccine to treat advance prostate cancer show a 20% lower risk of death among patients on the experimental option than those given a placebo.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)